Explore 6-MeO-DMT | PiHKAL

ChemSpider 23118889
PubChem 12017579
Wikipedia, see List of substituted tryptamines

TiHKAL #39 4-MeO-MIPT · #54 Tetrahydroharmine

Gessner, PK; Godse, DD; Krull, AH; McMullan, JM. Structure-activity relationships among 5-methoxy-N:N-dimethyltryptamine, 4-hydroxy-N:N-dimethyltryptamine (psilocin) and other substituted tryptamines. Life Sci., 1 Mar 1968, 7 (5), 267–277. 362 kB. https://doi.org/10.1016/0024-3205(68)90200-2 #6MeO-DMT

Lyon, RA; Titeler, M; Seggel, MR; Glennon, RA. Indolealkylamine analogs share 5-HT₂ binding characteristics with phenylalkylamine hallucinogens. Eur. J. Pharmacol., 19 Jan 1988, 145 (3), 291–297. 533 kB. https://doi.org/10.1016/0014-2999(88)90432-3

Glennon, RA; Dukat, M; Grella, B; Hong, S; Costantino, L; Teitler, M; Smith, C; Egan, C; Davis, K; Mattson, MV. Binding of β-carbolines and related agents at serotonin (5-HT₂ and 5-HT_1A), dopamine (D₂) and benzodiazepine receptors. Drug Alcohol Depend., 1 Aug 2000, 60 (2), 121–132. 276 kB. https://doi.org/10.1016/S0376-8716(99)00148-9

Kline, TB; Benington, F; Morin, RD; Beaton, JM. Structure-activity relationships in potentially hallucinogenic N,N-dialkyltryptamines substituted in the benzene moiety. J. Med. Chem., 1 Jan 1982, 25 (8), 908–913. 845 kB. https://doi.org/10.1021/jm00350a005 #5 NMR,IR

Schulze-Alexandru, M; Kovar, K; Vedani, A. Quasi-atomistic receptor surrogates for the 5-HT_2A receptor: A 3D-QSAR study on hallucinogenic substances. Quant. Struct.-Act. Relat., 1 Dec 1999, 18 (6), 548–560. 312 kB. https://doi.org/10.1002/(SICI)1521-3838(199912)18:6<548::AID-QSAR548>3.0.CO;2-B #S31

Phipps, SM; Grundmann, O. Pharmacology and structure-activity relationship of natural products with psychoactive effects from Salvia divinorum, Mitragyna speciosa, and Ayahuasca. In Stud. Nat. Prod. Chem.; , Elsevier, 1 Jan 2017; pp 1–44. 1.4 MB. https://doi.org/10.1016/B978-0-444-63930-1.00001-6 #6-Methoxy-DMT

Glennon, RA; Young, R; Rosecrans, JA; Kallman, MJ. Hallucinogenic agents as discriminative stimuli: A correlation with serotonin receptor affinities. Psychopharmacology, 1 May 1980, 68 (2), 155–158. 395 kB. https://doi.org/10.1007/BF00432133 #6-OMe DMT

Dunlap, LE; Azinfar, A; Ly, C; Cameron, LP; Viswanathan, J; Tombari, RJ; Myers-Turnbull, D; Taylor, JC; Grodzki, AC; Lein, PJ; Kokel, D; Olson, DE. Identification of psychoplastogenic N,N-dimethylaminoisotryptamine (isoDMT) analogues through structure–activity relationship studies. J. Med. Chem., 13 Feb 2020, 63 (3), 1142–1155. 12.7 MB. https://doi.org/10.1021/acs.jmedchem.9b01404 #30 MS,NMR,IR,TLC

Cameron, LP; Tombari, RJ; Lu, J; Pell, AJ; Hurley, ZQ; Ehinger, Y; Olson, DE. A non-hallucinogenic psychedelic analogue with therapeutic potential. Nature, 1 Jan 2021, 589 (7842), 474–479. 10.5 MB. https://doi.org/10.1038/s41586-020-3008-z #6-MeO-DMT MS,NMR,IR

Dong, C; Ly, C; Dunlap, LE; Vargas, MV; Sun, J; Hwang, I; Azinfar, A; Oh, WC; Wetsel, WC; Olson, DE; Tian, L. Psychedelic-inspired drug discovery using an engineered biosensor. Cell, 13 May 2021, 184 (10), 2779-2792.e18. 8.3 MB. https://doi.org/10.1016/j.cell.2021.03.043 #6-MeO NMR

Glennon, RA; Gessner, PK. Serotonin receptor binding affinities of tryptamine analogues. J. Med. Chem., 1 Jan 1979, 22 (4), pp 428–432. 731 kB. https://doi.org/10.1021/jm00190a014 #21

Glennon, RA; Rosecrans, JA. Indolealkylamine and phenalkylamine hallucinogens: A brief overview. Neurosci. Biobehav. Rev., 1 Jan 1982, 6 (4), 489–497. 895 kB. https://doi.org/10.1016/0149-7634(82)90030-6 #3g

Gupta, SP; Singh, P; Bindal, MC. QSAR studies on hallucinogens. Chem. Rev., 1 Dec 1983, 83 (6), 633–649. 2.8 MB. https://doi.org/10.1021/cr00058a003 #85

4-HO-MET · 4-Hydroxy-N-methyl-N-ethyltryptamine

5-MeO-DMT · 5-Methoxy-N,N-dimethyltryptamine · N,N,O-TMS · OMB

5-MeO-α,N-DMT · 5-MeO-α-methyl-NMT · 5-Methoxy-α-methyl-N-methyltryptamine · α,N,O-TMS

1-MeO-DMT · 1-Methoxy-N,N-dimethyltryptamine

1-Methyl-4-HO-DMT · 1-Methyl-4-hydroxy-N,N-dimethyltryptamine · 1-Methylpsilocin · CMY

5-MeO-AET · 5-Methoxy-α-ethyltryptamine

4-MeO-DMT · 4-Methoxy-N,N-dimethyltryptamine · PSOM

7-MeO-DMT · 7-Methoxy-N,N-dimethyltryptamine

5-HO-TMT⁺ · 5-HTQ · 5-Hydroxy-N,N,N-trimethyltryptamine⁺

5-MeO-NET · 5-Methoxy-N-ethyltryptamine

2-Methyl-4-HO-DMT · 2-Methyl-4-hydroxy-N,N-dimethyltryptamine · 2-Methylpsilocin

4-HO-α-methyl-DMT · 4-Hydroxy-α-methyl-N,N-dimethyltryptamine · α-Methylpsilocin

4-HO-DMHT

1-Methyl-5-HO-DMT · 1-Methyl-5-hydroxy-N,N-dimethyltryptamine · 1-Methylbufotenine

5-PrO-T · 5-Propoxytryptamine

5-IPrO-T · 5-Isopropoxytryptamine

5-EtO-NMT · 5-Ethoxy-N-methyltryptamine

10611

5-HO-NIPT · 5-Hydroxy-N-isopropyltryptamine

6-MeO-iso-DMT · 6-Methoxy-N,N-dimethyl-isotryptamine

5-MeO-iso-DMT · 5-Methoxy-N,N-dimethyl-isotryptamine

4-Isobutylaminorex

4-tert-Butylaminorex

4-Methyl-5-HO-DMT · 4-Methyl-5-hydroxy-N,N-dimethyltryptamine · 4-Methylbufotenin

Acetyl-norfentanyl

Ritalinamide · Ritalinic acid amide

4-HO-NIPT · 4-Hydroxy-N-isopropyltryptamine

5-EtO-AMT · 5-Ethoxy-α-methyltryptamine

7-MeO-iso-DMT · 7-Methoxy-N,N-dimethyl-isotryptamine

4-MeO-iso-DMT · 4-Methoxy-N,N-dimethyl-isotryptamine

4-HO-TMT⁺ · 4-Hydroxy-N,N,N-trimethyltryptamine⁺ · Dephosphorylated aeruginascin

7-Methyl-4-HO-DMT · 7-Methyl-4-hydroxy-N,N-dimethyltryptamine · 7-Methylpsilocin

5-Methyl-4-HO-DMT · 5-Methyl-4-hydroxy-N,N-dimethyltryptamine · 5-Methylpsilocin

7-MeO-NET · 7-Methoxy-N-ethyltryptamine